UNIT 4 Flashcards

1
Q

Trade names found in a specific country or region manufacturer specific

A

brand name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Used to refer to the drug in scientific and professional literature

A

generic name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Other names or accepted abbreviations of the generic drug

A

synonyms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Unique systematic classification of medications

It is defined by their therapeutic use (the pathology they are intended to treat

A

therapeutic category

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Information pertaining to appropriate indications of the drug

May include both FDA approved and non-FDA approved indications

A

Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Controlled substance classification for the Drug Enforcement Agency (DEA)

US schedules are l to V varies by country and sometimes by state

A

restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Five categories established by the FDA to indicate the potential of a systemically absorbed drug for causing birth defects

A

pregnancy risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Information pertinent to or associated with the use of the drug as it relates to cinical effects on fetus breast-feedingflactation and clinical effects on infants

A

pregnancy/breast feeding implications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Information pertaining to inappropriate use of the drug

An absolute prohibition to the use of the drug

A

Contraindications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Side effects of the drug usually grouped by percentage of incidence and/or body system.

It is an unwanted or harmful reaction experienced following the administration of a drug or combination of drugs under normal conditions of use and is suspected to be related to the drug

A

Adverse Reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Precautionary considerations hazardous conditions related to use of the drug and disease states or patient populations in which the drug should be cautiously used

__________ are less restrictive alert to health professionals

__________ are information used to alert health professionals to certain dangers or restrictions in the Use of certain drugs

A

Warnings/Precautions

  • Precautions
  • Warnings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Comments and/or considerations offered when appropriate

Includes signs and symptoms of excess drug and suggested management of the patient

A

overdosage/toxicology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indicates the capability of a drug to alter the effects of another drug once they are given together

Identifies whether a drug is an inhibitor, an inducer or a substance of specific enzyme.

A

drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Information regarding storage of product or steps for reconstitution

Provides the time and conditions for which a solution or mixture will maintain full potency

The degree to which or the length of time that the drug is resistant to change

A

stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How the drug works to elicit a response

It is the specific means by which a drug achieves its effect

A

mechanism of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The magnitude of a drug’s effect depending on its concentration at the site of action

____________ is expressed in onset of action and duration of action. It refers to the biological response of drugs, expressed in terms of absorption, distribution, metabolism and excretion

_____________ refers to the movement of drugs through the body

A

Pharmacodynamics
Pharmacokinetics

Pharmacodynamics and Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amount of the drug to be typically given or taken during therapy for children and adults

Includes dosing adjustment or comments for renal or hepatic impairment, and other suggested dosing requirements.

A

usual dosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Information offered for appropriate food, nutrition and/or alcohol

A

dietary consideration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The process of giving a therapeutic agent to a patient

Information regarding the recommended final concentrations, rates of administration for parenteral drugs, or other guidelines when giving the medication

A

administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Laboratory tests and patient physical parameters that should be monitored for safely and efficacy of drug therapy

The parameters used to attain therapeutic response that is safe and prevent toxicity

A

monitoring parameters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Therapeutic and toxic serum concentrations listed including peak and trough levels

A

reference range

20
Q

Listing of assay Interferences, when relevant

May indicate the alterations brought about by drug use on blood, serum and urine tests

A

testing interactions

21
Q

Specific information pertinent for the patient

A

patient information

22
Q

Includes additional instructions for the administration of the drug and monitoring tips from the nursing perspective

Are used to asses a patient and his environment before medication administration and monitor for skie effects and effectiveness of medication after administration

A

nursing implications

23
Q

Information with regard to form strength and availability of the drug

It is defined as the physical form of a dose of a chemical compound used as a drug or medication

Intended for administration or consumption to treat or prevent an illness of disease.

A

dosage forms

24
Q

Directions usually for preparing liquid formulations frorn solid drug products

May include stability information and references

a drug specially prepared by a pharmacist because an appropriate drug is not readily available

A

extemporaneous preparations

25
Q

pharmaceutical dosage forms

A
  • dosage form
  • drug product
  • active pharmaceutical ingredient
  • excipient
26
Q

A formulation containing a specific quantity of active ingredients in combination with one or more excipients

A

dosage forms

27
Q

The finished dosage from that contains the active ingredient

A

drug product

28
Q

The active pharmaceutical ingredient (API) or the component that produces the pharmacologic activity

A

API

29
Q

The inactive ingredient present in the dosage form

A

excipient

30
Q

Dispensing ophthalmic, nasal, otic or oral liquids to be administered by drop

A

dropper bottles

31
Q

Dispensing solid dosage forms such as capsules or tablets

A

round vials

32
Q

Dispensing liquids of low viscosity

A

prescription bottles

33
Q

Dispensing bulk powders, large quantities of tablets or capsules or viscous liquids that cannot be poured readily from a narrow-neck standard prescription bottles

A

wide mouth bottles

34
Q

Dispensing semi-solid dosage forms such as ointment, cream and gel

A

collapsible tubes

35
Q

Dispensing powders applied by sprinkling

A

sifter top containers

36
Q

Dispensing suppositories and powders prepared in packets

A

hinged-lid/slide boxes

37
Q

For applying liquid medication onto the skin or wound

A

applicator boxes

38
Q

Pressurized metal or plastic bottle used to dispense liquid or powder content as mist or foam

A

aerosols

39
Q

A type of bottle required by pharmaceutical standards for preparations sensitive to light

A

amber-colored bottles

40
Q

The least reactive glass available for containers which can be used for all applications

used for all laboratory apparatus in general

package water for injection

A

USP TYPE 1
borosilicate glass

41
Q

It contains higher levels of sodium hydroxide and calcium oxide therefore making it less resistant to leaching that Type 1 but it is more resistant than Type 2: can be used for all products that remain below pH 7 for their shelf life

A

USP TYPE 2
soda-lime-silica-glass

42
Q

The container acceptable for packaging some dry powders which are subsequently dissolved to make solutions or buffers

It is also suitable for packaging liquid formulations that prove to be insensitive to alkali

A

USP TYPE 3
soda-lime glass

43
Q

A general-purpose glass and is used for non-parenteral applications where chemical durability and heat shock are not factors

these are frequent containers for capsules, tablets and topical products

A

USP TYPE NP Soda lime glass

44
Q

Used in prescriptions and finished manufactured products except parenteral and ophthalmic solutions

A

purified water USP

45
Q

Free of pyrogen, used as solvent for the preparation of parenteral solutions

A

water for injection

46
Q

Packaged in single-dose containers of type I and II and does not exceed capacity of 1L

A

sterile water for injection

47
Q

contains one or more suitable microbial agents. It is packaged in single or multi-dose containers of type I and II and does not exceed capacity of 30mL

A

bacteriostatic water for injection

48
Q

Does not contain microbial agents and is not used for parenteral administration or sterile dosage forms.

A

sterile water for inhalation

49
Q

Sterilized and does not contain microbial agents or added substances

A

sterile water for irrigation